MLTX (MOONLAKE IMMUNOTHERAPEUTICS) is held by 79 institutional investors as of Q1 2026. Largest holders: JANUS HENDERSON GROUP PLC ($64.3M), D. E. Shaw & Co., Inc. ($44.6M), Point72 Asset Management, L.P. ($25.5M). Net institutional sentiment: Mixed.
See how MLTX's score breaks down across 4 SEC sources
Showing 1-20 of 88
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer